BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price traded down 8.5% on Monday . The company traded as low as $0.2058 and last traded at $0.2058. 1,613,624 shares were traded during trading, a decline of 97% from the average session volume of 62,169,492 shares. The stock had previously closed at $0.2250.
BioRestorative Therapies Trading Down 8.5%
The company has a market cap of $337.44 million, a P/E ratio of -0.19 and a beta of 102.36. The business has a 50 day moving average price of $0.25 and a 200-day moving average price of $0.78.
About BioRestorative Therapies
BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.
The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
